Farah R, Farah R, Makhoul N
Department of Internal Medicine F, Western Galilee Hospital, RO.Box 21, Nahariya 22100, Israel.
Int J Clin Pharmacol Ther. 2005 Sep;43(9):441-3. doi: 10.5414/cpp43441.
A further new case of sarcoidosis associated with the use of interferon (IFN) in the classical treatment of chronic hepatitis C (CHC) is reported. During the last two years, more than 20 cases of interferon-induced sarcoidosis have been described in the literature and about half of these cases have involved CHC. Therefore this disorder appears more common than originally thought two years ago, possibly due to the more frequent use of interferon therapy and an improvement in the methods of diagnosis.
报告了1例在慢性丙型肝炎（CHC）经典治疗中使用干扰素（IFN）引发结节病的新病例。在过去两年中，文献中已描述了20多例干扰素诱发的结节病，其中约一半病例与CHC有关。因此，这种疾病似乎比两年前最初认为的更为常见，这可能是由于干扰素治疗的使用更加频繁以及诊断方法的改进。
